Immunoblotting of JJN3 cell lysates showed that treatment by ARQ-197 reduced phospho-c-Met (Y1234/1235) and c-Met (EP1454Y) protein expression, consistent with previous findings using human myeloma cell lines [30]. The gene discussed is MET; the disease is plasma cell myeloma.